AMED Amedisys

Amedisys, Inc. engages in the provision of healthcare services. It operates through the following business segments: Home Health, Hospice, and Personal Care. The Home Health segment delivers services in the homes of individuals who may be recovering from an illness, injury, or surgery. The Hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. The Personal Care segment gives patients assistance with the essential activities of daily living. The company was founded by William F. Borne in 1982 and is headquartered in Baton Rouge, LA.
Company profile
Ticker
AMED
Exchange
Website
CEO
Paul Kusserow
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
IRS number
113131700
AMED stock data
()
News
P/E Ratio Insights for Amedisys
25 Feb 21
Amedisys: Q4 Earnings Insights
24 Feb 21
Amedisys Q4 EPS $1.49 Beats $1.47 Estimate, Sales $550.70M Miss $553.37M Estimate
24 Feb 21
Earnings Scheduled For February 24, 2021
24 Feb 21
Benchmark Maintains Buy on Amedisys, Raises Price Target to $325
23 Feb 21
Press releases
Calendar
25 Feb 21
11 Apr 21
31 Dec 21
Financial summary
Quarter (USD) |
Dec 20 | Sep 20 | Jun 20 | Mar 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) |
Dec 20 | Dec 19 | Dec 18 | Dec 17 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Financial data from Amedisys earnings reports.
Cash burn rate (estimated) | Burn method: Change in cash | Burn method: Operating income/loss | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 83.36M | 83.36M | 83.36M | 83.36M | 83.36M | 83.36M |
Cash burn (monthly) | 10.7M | 1.09M | (positive/no burn) | (positive/no burn) | (positive/no burn) | (positive/no burn) |
Cash used (since last report) | 36.1M | 3.69M | n/a | n/a | n/a | n/a |
Cash remaining | 47.25M | 79.66M | n/a | n/a | n/a | n/a |
Runway (months of cash) | 4.4 | 72.8 | n/a | n/a | n/a | n/a |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Apr 21 | Kemmerly David L | Common Stock | Sell | Dispose S | No | Yes | 270 | 503 | 135.81K | 20,913 |
31 Mar 21 | Ginn Scott G | Common Stock | Sell | Dispose S | No | Yes | 260.4 | 975 | 253.89K | 29,109 |
31 Mar 21 | Ginn Scott G | Common Stock | Option exercise | Aquire M | No | No | 27.35 | 975 | 26.67K | 30,084 |
31 Mar 21 | Ginn Scott G | Stock Option Common Stock | Option exercise | Dispose M | No | No | 27.35 | 975 | 26.67K | 1,950 |
1 Mar 21 | Perkins Bruce D | Common Stock | Buy | Aquire P | No | No | 259.3755 | 1,000 | 259.38K | 28,901 |
26 Feb 21 | Ginn Scott G | Common Stock | Sell | Dispose S | No | Yes | 264.15 | 975 | 257.55K | 29,109 |
26 Feb 21 | Ginn Scott G | Common Stock | Option exercise | Aquire M | No | No | 27.35 | 975 | 26.67K | 30,084 |
26 Feb 21 | Ginn Scott G | Stock Option Common Stock | Option exercise | Dispose M | No | No | 27.35 | 975 | 26.67K | 2,925 |
25 Feb 21 | Bohnert Denise M. | Common Stock | Sell | Dispose S | No | Yes | 274.44 | 70 | 19.21K | 13,276 |
Institutional ownership Q4 2020
Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.
88.6% owned by funds/institutions
13F holders |
Current |
---|---|
Total holders | 394 |
Opened positions | 52 |
Closed positions | 54 |
Increased positions | 146 |
Reduced positions | 146 |
13F shares |
Current |
---|---|
Total value | 10.17B |
Total shares | 29.09M |
Total puts | 185.6K |
Total calls | 182.5K |
Total put/call ratio | 1.0 |
Largest owners |
Shares | Value |
---|---|---|
BLK Blackrock | 3.98M | $1.17B |
Vanguard | 3.03M | $887.95M |
Wellington Management | 2.45M | $717.34M |
TROW T. Rowe Price | 1.56M | $457.73M |
JPM JPMorgan Chase & Co. | 1.14M | $333.68M |
IVZ Invesco | 943.23K | $276.68M |
STT State Street | 755.21K | $221.53M |
William Blair Investment Management | 750.51K | $220.15M |
Riverbridge Partners | 739.23K | $216.84M |
WFC Wells Fargo & Co. | 642.7K | $188.52M |
Financial report summary
?Risks
- Federal and state changes to reimbursement and other aspects of Medicare and Medicaid could have a material adverse effect on our business and consolidated financial condition, results of operations and cash flows.
- Quality reporting requirements may negatively impact Medicare reimbursement.
- Value-based purchasing may negatively impact Medicare reimbursement.
- Any economic downturn, deepening of an economic downturn, continued deficit spending by the Federal Government or state budget pressures may result in a reduction in payments and covered services.
- Future cost containment initiatives undertaken by private third party payors may limit our future revenue and profitability.
- Our business may be materially adversely affected by the ongoing COVID-19 pandemic.
- A shortage of qualified registered nursing staff and other clinicians, such as therapists and nurse practitioners, could materially impact our ability to attract, train and retain qualified personnel and could increase operating costs.
- Because we are limited in our ability to control rates received for our services, our business and consolidated financial condition, results of operations and cash flows could be materially adversely affected if we are not able to maintain or reduce our costs to provide such services.
- If we are unable to provide consistently high quality of care, our business will be adversely impacted.
- If we are unable to maintain relationships with existing patient referral sources, our business and consolidated financial condition, results of operations and cash flows could be materially adversely affected.
- Possible changes in the case mix of patients, as well as payor mix and payment methodologies, could have a material adverse effect on our business and consolidated financial condition, results of operations and cash flows.
- Our failure to negotiate favorable managed care contracts, or our loss of existing favorable managed care contracts, could have a material adverse effect on our business and consolidated financial condition, results of operations and cash flows.
- Our industry is highly competitive, with few barriers to entry in certain states.
- Our business depends on our information systems. A cyber-attack, security breach or our inability to effectively integrate, manage and keep our information systems secure and operational could disrupt our operations.
- Our insurance liability coverage may not be sufficient for our business needs.
- We may be subject to substantial malpractice or other similar claims.
- If we are unable to maintain our corporate reputation, our business may suffer.
- A write off of a significant amount of intangible assets or long-lived assets could have a material adverse effect on our consolidated financial condition and results of operations.
- Our operations could be impacted by natural disasters.
- Our growth strategy depends on our ability to acquire additional care centers and integrate and operate these care centers effectively. If our growth strategy is unsuccessful or we are not able to successfully integrate newly acquired care centers into our existing operations, our business and consolidated financial condition, results of operations and cash flows could be materially adversely affected.
- The indemnification provisions of acquisition agreements by which we have acquired companies may not fully protect us and as a result we may face unexpected liabilities.
- State efforts to regulate the establishment or expansion of health care providers could impair our ability to expand our operations.
- Federal regulation may impair our ability to consummate acquisitions or open new care centers.
- We are subject to extensive government regulation. Any changes to the laws and regulations governing our business, or to the interpretation and enforcement of those laws or regulations, could have a material adverse effect on our business and consolidated financial condition, results of operations and cash flows.
- We face periodic and routine reviews, audits and investigations under our contracts with federal and state government agencies and private payors, and these audits could have adverse findings that may negatively impact our business.
- If a care center fails to comply with the conditions of participation in the Medicare program, that care center could be subjected to sanctions or terminated from the Medicare program.
- We are subject to federal and state laws that govern our financial relationships with physicians and other health care providers, including potential or current referral sources.
- We may face significant uncertainty in the industry due to government health care reform.
- Delays in payment may cause liquidity problems.
- Changes in units of payment for home health agencies could reduce our Medicare home health reimbursement levels.
- The volatility and disruption of the capital and credit markets and adverse changes in the United States and global economies could impact our ability to access both available and affordable financing, and without such financing, we may be unable to achieve our objectives for strategic acquisitions and internal growth.
- Our indebtedness could impact our financial condition and impair our ability to fulfill other obligations.
- The agreements governing our indebtedness contain various covenants that limit our discretion in the operation of our business and our failure to satisfy requirements in these agreements could have a material adverse effect on our business and consolidated financial condition, results of operations and cash flows.
- The price of our common stock may be volatile.
- Our Board of Directors may use anti-takeover provisions or issue stock to discourage a change of control.
Management Discussion
- ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
- We are a provider of high-quality in-home healthcare and related services to the chronic, co-morbid, aging American population, with approximately 75%, 74% and 73% of our revenue derived from Medicare for 2020, 2019 and 2018, respectively.
- Our operations involve servicing patients through our three reportable business segments: home health, hospice and personal care. Our home health segment delivers a wide range of services in the homes of individuals who may be recovering from an illness, injury or surgery. Our hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. Our personal care segment provides patients assistance with the essential activities of daily living. As of December 31, 2020, we owned and operated 320 Medicare-certified home health care centers, 180 Medicare-certified hospice care centers and 14 personal-care care centers, including unconsolidated joint ventures, in 39 states within the United States and the District of Columbia.
Content analysis
?
Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
absence, acquistion, Aid, amplified, ASAP, AseraCare, attending, attestation, belonging, billion, BrightStar, career, caregiving, categorize, category, Chairman, collaboration, color, convenient, correlated, count, county, decided, deep, density, dispersed, doctor, driver, drop, drove, easily, economy, efficacy, empowerment, endeavor, evidenced, facilitate, Facilitation, feedback, feel, Fifty, flex, fortunate, FR, franchise, front, great, heavily, hedging, Heritage, hit, Hopsice, house, IAS, imperative, interdisciplinary, intraperiod, invoice, job, kickback, learning, listening, LP, magnitude, mental, mile, milling, missed, moderated, navigated, operationalize, operationalizing, outbreak, outflow, outlook, pandemic, Passion, passionate, permanent, PPE, predominately, PRF, priority, prolonged, protocol, pulse, quantity, quarantine, quartile, quickly, rebounded, relaxed, relief, remittance, repaid, sequestration, shown, slowdown, SNF, SPIRIT, spiritual, spread, staggered, steady, strike, supply, susceptible, systematic, talent, Teladoc, telehealth, temporarily, town, track, traditional, transportation, treat, trend, uniformly, unintentional, unrest, unsolicited, upfront, utmost, vaccinated, vaccination, vaccine, vendor, vision, voice, week, widespread, withdrawal, woman, Women, workplan
Removed:
adding, admitted, al, appointed, attribute, Bach, Balanced, begin, binding, certifying, CHIP, concealing, consecutive, creation, database, dismissal, divisional, doc, formula, fourteenth, Hampshire, hostile, inorganic, Intercity, intermediary, Lowered, MACRA, Middle, misrepresenting, Mississippi, move, MSW, Obama, ordering, organic, play, PPS, practitioner, prejudice, promissory, Puerto, pure, putative, ready, Reauthorization, recently, recording, reimbursing, remeasured, remeasurement, rent, repealed, replaced, restructuring, retained, Retirement, revising, Rico, RN, scheme, settle, subsequently, twentieth, unnecessary, unspecified, upcoding, violated
Financial reports
10-K
2020 FY
Annual report
25 Feb 21
10-Q
2020 Q3
Quarterly report
29 Oct 20
10-Q
2020 Q2
Quarterly report
29 Jul 20
10-Q
2020 Q1
Quarterly report
7 May 20
10-K
2019 FY
Annual report
19 Feb 20
10-Q
2019 Q3
Quarterly report
30 Oct 19
10-Q
2019 Q2
Quarterly report
1 Aug 19
10-Q
2019 Q1
Quarterly report
1 May 19
10-K
2018 FY
Annual report
28 Feb 19
10-Q
2018 Q3
Quarterly report
30 Oct 18
Current reports
8-K
Regulation FD Disclosure
15 Mar 21
8-K
Amedisys Reports Fourth Quarter and Year End 2020 Financial Results
24 Feb 21
8-K
Regulation FD Disclosure
13 Jan 21
8-K
Regulation FD Disclosure
23 Dec 20
8-K
Departure of Directors or Certain Officers
15 Dec 20
8-K
Amedisys Reports Third Quarter 2020 Financial Results
28 Oct 20
8-K
Other Events
10 Aug 20
8-K
Amedisys Reports Second Quarter 2020 Financial Results
28 Jul 20
8-K
Entry into a Material Definitive Agreement
15 Jun 20
8-K
Amedisys Completes Acquisition of AseraCare Hospice
1 Jun 20
Registration and prospectus
S-8
Registration of securities for employees
6 Jun 18
S-8
Registration of securities for employees
25 Jun 15
S-8
Registration of securities for employees
25 Jun 12
S-8
Registration of securities for employees
15 Jul 08
S-3
Shelf registration
19 Aug 07
S-8
Registration of securities for employees
21 Jun 07
424B1
Prospectus with pricing info
16 Nov 06
FWP
Free writing prospectus
16 Nov 06
S-3/A
Shelf registration (amended)
2 Nov 06
S-3
Shelf registration
26 Oct 06
Proxies
DEFA14A
Additional proxy soliciting materials
24 Apr 20
DEF 14A
Definitive proxy
24 Apr 20
DEFA14A
Additional proxy soliciting materials
26 Apr 19
DEF 14A
Definitive proxy
26 Apr 19
DEFA14A
Additional proxy soliciting materials
25 Apr 18
DEF 14A
Definitive proxy
25 Apr 18
DEF 14A
Definitive proxy
24 Apr 17
DEFA14A
Additional proxy soliciting materials
24 Apr 17
DEF 14A
Definitive proxy
21 Apr 16
DEF 14A
Definitive proxy
29 Apr 15
Other
UPLOAD
Letter from SEC
17 Dec 20
CORRESP
Correspondence with SEC
23 Nov 20
UPLOAD
Letter from SEC
19 Nov 20
UPLOAD
Letter from SEC
30 Jan 14
CORRESP
Correspondence with SEC
16 Jan 14
CORRESP
Correspondence with SEC
17 Dec 13
UPLOAD
Letter from SEC
16 Dec 13
UPLOAD
Letter from SEC
24 Jul 11
CORRESP
Correspondence with SEC
27 Jun 11
UPLOAD
Letter from SEC
23 Jun 11
Ownership
4
AMEDISYS / Scott G Ginn ownership change
2 Apr 21
4
AMEDISYS / David L Kemmerly ownership change
2 Apr 21
4
AMEDISYS / BRUCE D PERKINS ownership change
3 Mar 21
4
AMEDISYS / Scott G Ginn ownership change
2 Mar 21
4
AMEDISYS / Denise M. Bohnert ownership change
1 Mar 21
4
AMEDISYS / Christopher Gerard ownership change
23 Feb 21
4
AMEDISYS / Sharon Brunecz ownership change
23 Feb 21
4
AMEDISYS / Michael Paul North ownership change
23 Feb 21
4
AMEDISYS / Denise M. Bohnert ownership change
23 Feb 21
4
AMEDISYS / David L Kemmerly ownership change
23 Feb 21
Transcripts
2020 Q4
Earnings call transcript
26 Feb 21
2020 Q3
Earnings call transcript
31 Oct 20
2020 Q3
Earnings call transcript
29 Oct 20
2020 Q2
Earnings call transcript
29 Jul 20
2020 Q1
Earnings call transcript
10 May 20
2019 Q4
Earnings call transcript
19 Feb 20
2019 Q3
Earnings call transcript
30 Oct 19
2019 Q2
Earnings call transcript
1 Aug 19
2019 Q1
Earnings call transcript
2 May 19
2018 Q4
Earnings call transcript
1 Mar 19